Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Horse of the Year Charismatic Dies
- Classic Empire Out of Fountain of Youth
- Epicharis Earns Japan's Kentucky Derby Bid
- Zakaroff 48-1 Stunner in El Camino Real Derby
- Gold Dream Punches Ticket to BC Classic
- Mo Town Set for 3-Year-Old Debut in Risen Star
- Lucky Pulpit, Sire of 'Chrome', Dies of a Heart Attack
- Royal Delta Half Brother Scores on Gulfstream Turf
- Terra Promessa Goes Gate to Wire in Bayakoa
- Curlin's Approval Stretches Out Handily in Royal Delta